Chong Kun Dang Pharmaceutical
185750.KO
59.20 USD
0.78
+1.34%
c
Overview
Last close
59.20 usd
Market cap
780.07M usd
52 week high
80.07 usd
52 week low
48.18 usd
Target price
79.36 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.3727
Price/Book Value
1.1578
Enterprise Value
788.08M usd
EV/Revenue
0.6992
EV/EBITDA
8.8876
Key financials
Revenue TTM
572.75M usd
Gross Profit TTM
227.38M usd
EBITDA TTM
66.38M usd
Earnings per Share
N/A usd
Dividend
0.33 usd
Total assets
1.25B usd
Net debt
98.28M usd
About
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
- Symbol185750.KO
- ExchangeKO
- IsinKR7185750007
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Young-Joo Kim
- HeadquarterSeoul
- Web sitehttps://www.ckdpharm.com
Related indices
Related news
November 18
JAKOTA Stocks on November 17, 2023 